PMID: 9177225Jun 10, 1997Paper

Mutated mitogen-activated protein kinase: a tumor rejection antigen of mouse sarcoma

Proceedings of the National Academy of Sciences of the United States of America
H IkedaH Shiku

Abstract

The molecular basis of the polymorphic tumor rejection antigens of chemically induced sarcomas of inbred mice remains a mystery, despite the discovery of these antigens over 40 years ago and their critical importance to the foundation of tumor immunology. In an analysis of a panel of BALB/c 3-methylcholanthrene-induced tumors, we identified one tumor, CMS5, that elicited a strong cytotoxic T cell response with exquisite specificity for CMS5. A stable cloned line of T cells with this specificity (C18) was used to screen a CMS5 cDNA expression library. The gene encoding the C18-defined antigen was identified as a mutated form of a mouse mitogen-activated protein kinase, ERK2, and a peptide incorporating the resulting amino acid substitution (lysine to glutamine) was efficiently recognized by C18. Vaccination with this peptide elicited specific resistance to CMS5 challenge. Extensive efforts to isolate antigen-loss variants of CMS5 were unsuccessful, suggesting that the mutated mitogen-activated protein kinase is essential for maintenance of the malignant phenotype.

References

Oct 1, 1976·The Journal of Experimental Medicine·H ShikuH F Oettgen
Jul 1, 1979·Proceedings of the National Academy of Sciences of the United States of America·E NakayamaL J Old
Jan 1, 1977·Annual Review of Genetics·L J Old, E Stockert
Sep 1, 1992·European Journal of Immunology·B LethéT Boon
Jan 1, 1992·Immunogenetics·K Satyanarayana, J L Strominger
Dec 30, 1991·Annals of the New York Academy of Sciences·A Van PelT Boon
May 1, 1987·Proceedings of the National Academy of Sciences of the United States of America·B Seed, A Aruffo
Mar 1, 1987·Proceedings of the National Academy of Sciences of the United States of America·O LeoJ A Bluestone
Mar 1, 1988·Immunology Today·P K Srivastava, L J Old
Sep 1, 1985·Somatic Cell and Molecular Genetics·A Van PelT Boon
Jan 1, 1983·Advances in Cancer Research·T Boon
Mar 14, 1995·Proceedings of the National Academy of Sciences of the United States of America·Y NoguchiL J Old
Apr 12, 1994·Proceedings of the National Academy of Sciences of the United States of America·Y NoguchiL J Old
Sep 3, 1996·Proceedings of the National Academy of Sciences of the United States of America·A Y HuangE M Jaffee
Feb 3, 1997·The Journal of Experimental Medicine·M B BloomJ C Yang
Jan 1, 1964·Annual Review of Medicine·L J OLD, E A BOYSE
Feb 28, 1962·Annals of the New York Academy of Sciences·J B KIRSNER

❮ Previous
Next ❯

Citations

Jun 29, 2001·Current Opinion in Oncology·R G Maki
May 23, 2007·Molekuliarnaia biologiia·S A Nedospasov, D V Kuprash
Aug 4, 2011·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Christopher G TwittyBernard A Fox
Jun 24, 2006·The Journal of Clinical Investigation·Hiroyoshi NishikawaSacha Gnjatic
Jul 14, 2009·PloS One·Nisheeth Srivastava, Pramod K Srivastava
Feb 24, 2001·Cell Stress & Chaperones·S Basu, P K Srivastava
Jan 7, 2005·Cell Stress & Chaperones·Christopher V NicchittaJulie C Baker-Lepain
Jun 10, 1997·Proceedings of the National Academy of Sciences of the United States of America·G Klein
Aug 30, 2003·Proceedings of the National Academy of Sciences of the United States of America·Hiroyoshi NishikawaHiroshi Shiku
Mar 29, 2001·Proceedings of the National Academy of Sciences of the United States of America·T Matsutake, P K Srivastava
Nov 29, 2001·Proceedings of the National Academy of Sciences of the United States of America·H NishikawaH Shiku
Sep 24, 2014·The Journal of Experimental Medicine·Fei DuanPramod K Srivastava
Aug 22, 2008·Seminars in Immunology·Matthew R Buckwalter, Pramod K Srivastava
Feb 9, 2006·Current Opinion in Immunology·Pramod K Srivastava
Jan 20, 2017·Nature·Daniel S Chen, Ira Mellman
Nov 28, 2000·International Journal of Cancer. Journal International Du Cancer·T OnoE Nakayama
Jan 11, 2019·The Journal of Clinical Investigation·Daisuke MuraokaHiroshi Shiku
Feb 14, 2006·The Journal of Biological Chemistry·Vesselin Mitaksov, Daved H Fremont
Jun 21, 2019·JCI Insight·Hakimeh Ebrahimi-NikPramod K Srivastava
Sep 24, 2005·The Journal of Immunology : Official Journal of the American Association of Immunologists·Hiroyoshi NishikawaHiroshi Shiku
Apr 23, 2003·The Journal of Immunology : Official Journal of the American Association of Immunologists·Akiko UenakaEiichi Nakayama
Oct 10, 2001·The Journal of Biological Chemistry·M A EmrickN G Ahn
Aug 24, 2005·The Journal of Immunology : Official Journal of the American Association of Immunologists·Yujun HuangLiang Qiao
Nov 5, 2019·The Journal of Clinical Investigation·Scott R WalshYonghong Wan
Oct 24, 2001·The Journal of Immunology : Official Journal of the American Association of Immunologists·D W MullinsV H Engelhard

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.